• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Weight loss surgery may reduce risk of developing type 2 diabetes

byAmir Tarsha, MSandXiaozhou Liu
November 3, 2014
in Chronic Disease, Endocrinology, Gastroenterology, Surgery
Reading Time: 3 mins read
Weight loss surgery may reduce risk of developing type 2 diabetes
Share on FacebookShare on Twitter

1. When compared to matched controls, obese patients without diabetes at baseline who underwent bariatric surgery had a lower incidence of developing type 2 diabetes up to 7 years after the procedure.

2. The positive effect of bariatric surgery was similar across all age groups and in both genders.

Evidence Rating Level: 2 (Good)           

Study Rundown: Obesity is rapidly becoming ubiquitous and the negative impact it has on nearly every organ system is well documented. Amongst other diagnoses, obese individuals are at an increased risk of developing type 2 diabetes. Traditional weight-loss regimens, which mainly focus on lifestyle changes, have high attrition rates and if weight is lost, patients may regain it rapidly. Bariatric surgery is a more radical option that many patients have had success with. This study aimed to investigate the preventative effect of bariatric surgery on the development of type 2 diabetes. This prospective cohort included obese individuals who had undergone bariatric surgery and compared them to matched controls who had not had the surgery. The patients were then followed for 7 years and the incidence of diabetes in each group was recorded. As hypothesized, the incidence of diabetes was significantly lower in the bariatric surgery group. The protective effect of bariatric surgery was consistent across age groups and both genders. The incidence of diabetes was significantly decreased regardless of the type of bariatric procedure (i.e. sleeve gastrectomy, laparoscopic gastric banding, or gastric bypass). Of note is that patients who underwent bariatric surgery were more likely to be prescribed statins, which may play a role in the development of diabetes. Furthermore, it is unclear if the expensive and more invasive nature of bariatric surgery made patient more committed to maintaining weight-loss during the follow-up period.

The study was funded by UK National Institute for Health Research.

Click to read the study, published today in The Lancet Diabetes & Endocrinology

RELATED REPORTS

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

Relevant Reading: Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of radomised controlled trials

In-Depth [prospective cohort]: The primary of endpoint of this study was the development of type 2 diabetes in obese subjects without diabetes at baseline, comparing those who had undergone bariatric surgery with those who had not. Only patients with a BMI of great than 30 and over the age of 20 were included. 2167 patients who had undergone bariatric surgery were included in the study. These patients were matched (by age, gender, BMI, and HbA1C) with controls who had not undergone the surgery. Three types of bariatric procedures were included in the study. 1053 patients underwent laparoscopic gastric banding, 795 had gastric bypass, and 317 had a sleeve gastrectomy.

At the end of the 7-year follow-up period, only 4.3% (95% confidence interval, [CI] 2.9-6.5) of bariatric surgery group developed diabetes, compared to 16.2% (95% CI 13.3-19.6) in the control group. The incidence rate was 5.7 diagnoses per 1000 person-years (95% CI 4.2-7.8) in the bariatric surgery group, compared with 28.2 (24.4-32.7) in the matched controls. The adjusted hazard rate for the development of type 2 diabetes in the bariatric surgery group was 0.2 (p < .0001). The protective effect of bariatric surgery did not vary significantly between age group or gender. The results suggest that for patients with a BMI >30 bariatric surgery is protective against the development of type 2 diabetes.

More from this author: Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer, Secondary mastoid obliteration improves quality of life for patients with chronic otitis media, Healthcare reform linked with reduced racial disparities in surgical care, VATS lobectomy may be preferred in COPD with non-small-cell lung cancer, One-on-one training leads to improved virtual reality laparoscopic performance

Image: PD/CDC

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: diabetes
Previous Post

Individually-taught, parent-implemented social intervention may improve autism outcomes

Next Post

Maternal verbal interaction more common than paternal during infancy

RelatedReports

Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Cost-related medication nonadherence associated with increased ED utilization
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

September 4, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Next Post
Maternal verbal interaction more common than paternal during infancy

Maternal verbal interaction more common than paternal during infancy

Patient Basics: Delusional Disorder

AAP policy supports consumption of only pasteurized dairy products

2 Minute Medicine Rewind October 26 – November 2, 2014

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.